Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 191

    1.

    The direct medical cost of type 2 diabetes.

    Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH.

    Diabetes Care. 2003 Aug;26(8):2300-4.PMID: 12882852 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Direct medical costs of complications resulting from type 2 diabetes in the U.S.

    O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ.

    Diabetes Care. 1998 Jul;21(7):1122-8.PMID: 9653606 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cost of managing complications resulting from type 2 diabetes mellitus in Canada.

    O'Brien JA, Patrick AR, Caro JJ.

    BMC Health Serv Res. 2003 Mar 21;3(1):7.PMID: 12659641 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.

    Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W, Dong F, Manninen D, Zbrozek AS, Kotsanos J, Garfield SA, Harris M.

    Diabetes Care. 1997 May;20(5):735-44.PMID: 9135935 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

    CDC Diabetes Cost-effectiveness Group.

    JAMA. 2002 May 15;287(19):2542-51.PMID: 12020335 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The progressive cost of complications in type 2 diabetes mellitus.

    Brown JB, Pedula KL, Bakst AW.

    Arch Intern Med. 1999 Sep 13;159(16):1873-80.PMID: 10493317 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Medical costs of managed care in patients with type 2 diabetes mellitus.

    Bhattacharyya SK, Else BA.

    Clin Ther. 1999 Dec;21(12):2131-42.PMID: 10645758 [PubMed - indexed for MEDLINE]Related articles

    9.

    Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.

    Guo JJ, Gibson JT, Gropper DM, Oswald SL, Barker KN.

    Am J Manag Care. 1998 Oct;4(10):1433-46.PMID: 10338736 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    11.

    Disease progression and cost of insulin dependent diabetes mellitus: development and application of a simulation model.

    Tomar RH, Lee S, Wu SY, Klein R, Klein BE, Moss SE, Fryback DG, Tollios JL, Sainfort F.

    J Soc Health Syst. 1998;5(4):24-37.PMID: 9785295 [PubMed - indexed for MEDLINE]Related articles

    12.

    The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes.

    Huang ES, Shook M, Jin L, Chin MH, Meltzer DO.

    Diabetes Care. 2006 Feb;29(2):259-64.PMID: 16443870 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.
    14.

    The health care costs of diabetic peripheral neuropathy in the US.

    Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA.

    Diabetes Care. 2003 Jun;26(6):1790-5.PMID: 12766111 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

    Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

    Clin Ther. 2003 Nov;25(11):2958-71.PMID: 14693318 [PubMed - indexed for MEDLINE]Related articles

    16.

    Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

    Brown JB, Nichols GA, Glauber HS, Bakst AW.

    Diabetes Care. 1999 Jul;22(7):1116-24.PMID: 10388977 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Valuing health-related quality of life in diabetes.

    Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH.

    Diabetes Care. 2002 Dec;25(12):2238-43.PMID: 12453967 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Economic outcomes associated with microvascular complications of type 2 diabetes mellitus: results from a US claims data analysis.

    Pelletier EM, Shim B, Ben-Joseph R, Caro JJ.

    Pharmacoeconomics. 2009;27(6):479-90. doi: 10.2165/00019053-200927060-00004.PMID: 19640011 [PubMed - indexed for MEDLINE]Related articles

    20.

    Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.

    Michaud K, Messer J, Choi HK, Wolfe F.

    Arthritis Rheum. 2003 Oct;48(10):2750-62.PMID: 14558079 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data